PHARMACEUTICAL ECONSULTING A/S — Credit Rating and Financial Key Figures
CVR number: 30815378
Naverland 2, 2600 Glostrup
sr@pec-services.com
tel: 43466366
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 6 946.67 | 8 276.39 | 6 778.72 | 5 578.65 | 5 538.00 |
| Employee benefit expenses | -3 909.84 | -5 166.11 | -5 932.66 | -5 891.98 | -6 342.82 |
| Total depreciation | -59.17 | -59.87 | -75.97 | -81.55 | - 136.48 |
| EBIT | 2 977.65 | 3 050.41 | 770.09 | - 394.89 | - 941.30 |
| Other financial income | 273.25 | 300.30 | 478.66 | 125.85 | 128.96 |
| Other financial expenses | - 235.44 | - 242.89 | - 241.62 | -34.35 | -79.63 |
| Pre-tax profit | 3 015.46 | 3 107.82 | 1 007.13 | - 303.39 | - 891.97 |
| Income taxes | - 670.33 | - 688.02 | - 227.51 | -80.24 | 248.12 |
| Net earnings | 2 345.13 | 2 419.81 | 779.62 | - 383.63 | - 643.85 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 41.21 | 160.98 | 125.21 | 43.66 | 1 079.09 |
| Tangible assets total | 41.21 | 160.98 | 125.21 | 43.66 | 1 079.09 |
| Other non-current investments | -0.00 | -0.00 | |||
| Other receivables | 34.63 | 21.95 | 22.58 | 23.23 | 23.90 |
| Investments total | 34.63 | 21.95 | 22.58 | 23.23 | 23.90 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 815.82 | 953.43 | 1 382.29 | 942.34 | 462.50 |
| Current amounts owed by group member comp. | 14 762.06 | 15 568.15 | 6 438.97 | 6 578.21 | 6 389.39 |
| Prepayments and accrued income | 12.28 | 75.94 | 23.74 | 40.36 | |
| Current other receivables | -0.00 | 7.00 | 0.10 | 0.03 | |
| Current deferred tax assets | 59.66 | 45.77 | 39.98 | 39.98 | 295.40 |
| Short term receivables total | 15 649.83 | 16 650.29 | 7 884.97 | 7 560.62 | 7 187.68 |
| Cash and bank deposits | 1 406.32 | 2 824.62 | 59.53 | 363.13 | 515.48 |
| Cash and cash equivalents | 1 406.32 | 2 824.62 | 59.53 | 363.13 | 515.48 |
| Balance sheet total (assets) | 17 131.99 | 19 657.84 | 8 092.29 | 7 990.63 | 8 806.14 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 500.00 | 500.00 | 500.00 | 500.00 | 500.00 |
| Retained earnings | 1 202.50 | 3 547.62 | 5 967.43 | 6 747.05 | 6 363.42 |
| Profit of the financial year | 2 345.13 | 2 419.81 | 779.62 | - 383.63 | - 643.85 |
| Shareholders equity total | 4 047.62 | 6 467.43 | 7 247.05 | 6 863.42 | 6 219.57 |
| Provisions | 7.30 | ||||
| Non-current deferred tax liabilities | 249.14 | ||||
| Non-current liabilities total | 249.14 | ||||
| Current loans from credit institutions | 80.00 | ||||
| Current trade creditors | 93.67 | 62.30 | 42.09 | 141.64 | 212.26 |
| Current owed to participating | 11.78 | 202.26 | |||
| Current owed to group member | 9 743.92 | 9 814.07 | 1 422.31 | ||
| Short-term deferred tax liabilities | 660.44 | 674.12 | 221.72 | ||
| Other non-interest bearing current liabilities | 2 586.34 | 2 639.92 | 581.44 | 973.80 | 413.30 |
| Current liabilities total | 13 084.37 | 13 190.41 | 845.24 | 1 127.22 | 2 330.13 |
| Balance sheet total (liabilities) | 17 131.99 | 19 657.84 | 8 092.29 | 7 990.63 | 8 806.14 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.